Annual EBITDA
$26.76M$31.07M+721.10%
Summary
- Current Value
- As of today, CTMX annual EBITDA is $26.76M, up +721.10% on
- Historical Performance
- CTMX annual EBITDA is up +123.61% over the past 3 years, and up +119.27% over the past 5 years
- All-Time High Comparison
- CTMX annual EBITDA is currently at its all-time high
- 3-Year Low Comparison
- CTMX annual EBITDA is +127.06% above its 3-year low of -$98.89M reached on an earlier date
- Sector Comparison
- CTMX annual EBITDA is higher than 81.86% of companies in Healthcare sector
EBITDA Chart
Add series to chart1/6
Series
SUGGESTED SERIES
Performance
| Metric | Date | Value | 1Y | 3Y | 5Y | 15Y |
|---|---|---|---|---|---|---|
| Annual EBITDA | $26.76M | +721.1% | +123.6% | +119.3% | +288.1% | |
| Quarterly EBITDA | -$15.73M | -446.6% | +44.3% | -10.5% | -380.3% | |
| TTM EBITDA | $24.43M | +185.6% | +122.8% | +135.6% | +845.6% | |
| Price | $4.14 | +263.2% | +64.3% | -41.9% | – | |
| PE Ratio | 9.90 | +241.4% | – | – | – | |
| Annual Revenue | $138.10M | +36.5% | +270.1% | +140.2% | +10000.0% | |
| Annual EPS | $0.38 | +4984.4% | +120.8% | +116.7% | +171.5% | |
| $25.00M | +485.5% | +121.5% | +117.7% | +268.0% | ||
| Annual Net Income | $31.87M | +5700.9% | +127.5% | +131.2% | +310.4% |
EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 3Y | $26.76M | at high | |
| 5Y | $26.76M | at high | |
| All | $26.76M | at high |
EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 3Y | -$98.89M | N/A | +127.1% |
| 5Y | -$113.34M | +123.6% | |
| All | -$138.88M | +119.3% |
EBITDA History
FAQ
What is the current annual EBITDA of CTMX?
As of today, CTMX annual EBITDA is $26.76M
What is 1-year change in CTMX annual EBITDA?
CTMX annual EBITDA is up +721.10% year-over-year
What is 3-year change in CTMX annual EBITDA?
CTMX annual EBITDA is up +123.61% over the past 3 years
How far is CTMX annual EBITDA from its all-time high?
CTMX annual EBITDA is currently at its all-time high
How does CTMX annual EBITDA rank versus sector peers?
CTMX annual EBITDA is higher than 81.86% of companies in Healthcare sector
When is CTMX next annual earnings release?
The next annual earnings release for CTMX is on
Quarterly EBITDA
-$15.73M$14.80M-1,575.61%
Summary
- Current Value
- As of today, CTMX quarterly EBITDA is -$15.73M, down -1575.61% on
- Historical Performance
- CTMX quarterly EBITDA is down -446.56% year-over-year, and up +44.26% over the past 3 years
- All-Time High Comparison
- CTMX quarterly EBITDA is currently -168.39% below its historical high of $23.01M set on
- 3-Year Low Comparison
- CTMX quarterly EBITDA is at its 3-year low
- Sector Comparison
- CTMX quarterly EBITDA is higher than 24.82% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| Quarterly EBITDA | -$15.73M | -1575.6% | -446.6% | +44.3% | -10.5% | |
| Annual EBITDA | $26.76M | – | +721.1% | +123.6% | +119.3% | |
| TTM EBITDA | $24.43M | -45.4% | +185.6% | +122.8% | +135.6% | |
| Price | $4.14 | +26.2% | +263.2% | +64.3% | -41.9% | |
| PE Ratio | 9.90 | +26.3% | +241.4% | – | – | |
| Quarterly Revenue | $5.96M | -68.0% | -82.2% | -46.5% | -66.5% | |
| Quarterly EPS | -$0.09 | -7083.3% | -228.1% | +80.5% | +72.9% | |
| -$14.17M | -1001.9% | -444.7% | +52.3% | +4.9% | ||
| Quarterly Net Income | -$14.23M | -9139.6% | -348.1% | +51.0% | +3.3% |
Quarterly EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $23.01M | -168.4% | |
| 3Y | $23.01M | -168.4% | |
| 5Y | $23.01M | -168.4% | |
| All | $23.01M | -168.4% |
Quarterly EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | -$15.73M | at low | |
| 3Y | -$15.73M | at low | |
| 5Y | -$30.63M | +48.6% | |
| All | -$36.77M | +57.2% |
Quarterly EBITDA History
FAQ
What is the current quarterly EBITDA of CTMX?
As of today, CTMX quarterly EBITDA is -$15.73M
What is CTMX quarterly EBITDA most recent change?
CTMX quarterly EBITDA was down -1575.61% on September 30, 2025
What is 1-year change in CTMX quarterly EBITDA?
CTMX quarterly EBITDA is down -446.56% year-over-year
How far is CTMX quarterly EBITDA from its all-time high?
CTMX quarterly EBITDA is currently -168.39% below its historical high of $23.01M set on March 31, 2025
How does CTMX quarterly EBITDA rank versus sector peers?
CTMX quarterly EBITDA is higher than 24.82% of companies in Healthcare sector
When is CTMX next earnings release?
The next earnings release for CTMX is on
TTM EBITDA
$24.43M$20.27M-45.36%
Summary
- Current Value
- As of today, CTMX TTM EBITDA is $24.43M, down -45.36% on
- Historical Performance
- CTMX TTM EBITDA is up +185.64% year-over-year, and up +122.83% over the past 3 years
- All-Time High Comparison
- CTMX TTM EBITDA is currently -45.36% below its historical high of $44.70M set on
- 3-Year Low Comparison
- CTMX TTM EBITDA is +127.26% above its 3-year low of -$89.61M reached on an earlier date
- Sector Comparison
- CTMX TTM EBITDA is higher than 78.52% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| TTM EBITDA | $24.43M | -45.4% | +185.6% | +122.8% | +135.6% | |
| Annual EBITDA | $26.76M | – | +721.1% | +123.6% | +119.3% | |
| Quarterly EBITDA | -$15.73M | -1575.6% | -446.6% | +44.3% | -10.5% | |
| Price | $4.14 | +26.2% | +263.2% | +64.3% | -41.9% | |
| PE Ratio | 9.90 | +26.3% | +241.4% | – | – | |
| TTM Revenue | $113.63M | -19.5% | -10.3% | +95.7% | +23.1% | |
| TTM EPS | $0.42 | -26.9% | +146.6% | +124.6% | +135.5% | |
| $24.84M | -42.4% | +270.2% | +122.0% | +134.9% | ||
| TTM Net Income | $28.02M | -41.6% | +102.6% | +125.1% | +152.2% |
TTM EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $44.70M | -45.4% | |
| 3Y | $44.70M | -45.4% | |
| 5Y | $44.70M | -45.4% | |
| All | $44.70M | -45.4% |
TTM EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | $24.43M | at low | |
| 3Y | -$89.61M | N/A | +127.3% |
| 5Y | -$106.97M | +122.8% | |
| All | -$108.29M | +122.6% |
TTM EBITDA History
FAQ
What is the current TTM EBITDA of CTMX?
As of today, CTMX TTM EBITDA is $24.43M
What is CTMX TTM EBITDA most recent change?
CTMX TTM EBITDA was down -45.36% on September 30, 2025
What is 1-year change in CTMX TTM EBITDA?
CTMX TTM EBITDA is up +185.64% year-over-year
How far is CTMX TTM EBITDA from its all-time high?
CTMX TTM EBITDA is currently -45.36% below its historical high of $44.70M set on June 30, 2025
How does CTMX TTM EBITDA rank versus sector peers?
CTMX TTM EBITDA is higher than 78.52% of companies in Healthcare sector
When is CTMX next earnings release?
The next earnings release for CTMX is on
EBITDA Formula
EBITDA = + + +
Data Sources & References
- CTMX Official Website www.cytomx.com
- Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/1501989/000119312525269477/0001193125-25-269477-index.htm
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1501989/000095017025034575/0000950170-25-034575-index.htm
- CTMX Profile on Yahoo Finance finance.yahoo.com/quote/CTMX
- CTMX Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/ctmx